Oncopeptides publishes report for Q2 2021
Go back to Oncopeptides publishes report for Q2 2021| Oncology Med, Inc. (NASDAQ: ONCO) | Delayed: 0.59 -0.03 (4.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.62 | 52 Week High | $0.00 | |||
| Open | $0.59 | 52 Week Low | $0.00 | |||
| Day High | $0.60 | P/E | N/A | |||
| Day Low | $0.56 | EPS | $0.00 | |||
| Volume | 783,987 | |||||
| Oncology Med, Inc. (NASDAQ: ONCO) | Delayed: 0.59 -0.03 (4.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.62 | 52 Week High | $0.00 | |||
| Open | $0.59 | 52 Week Low | $0.00 | |||
| Day High | $0.60 | P/E | N/A | |||
| Day Low | $0.56 | EPS | $0.00 | |||
| Volume | 783,987 | |||||
| Oncology Med, Inc. (NASDAQ: ONCO) | Delayed: 0.59 -0.03 (4.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.62 | 52 Week High | $0.00 | |||
| Open | $0.59 | 52 Week Low | $0.00 | |||
| Day High | $0.60 | P/E | N/A | |||
| Day Low | $0.56 | EPS | $0.00 | |||
| Volume | 783,987 | |||||
| Oncology Med, Inc. (NASDAQ: ONCO) | Delayed: 0.59 -0.03 (4.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.62 | 52 Week High | $0.00 | |||
| Open | $0.59 | 52 Week Low | $0.00 | |||
| Day High | $0.60 | P/E | N/A | |||
| Day Low | $0.56 | EPS | $0.00 | |||
| Volume | 783,987 | |||||



